Telesis Bio Inc Book/Share
What is the Book/Share of Telesis Bio Inc?
The Book/Share of Telesis Bio Inc is 0.00
What is the definition of Book/Share?
Book value per share is a company’s assets minus liabilities divided by the number of shares outstanding.
mrq (most recent quarter)
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Book/Share of companies in the Health Care sector on NASDAQ compared to Telesis Bio Inc
What does Telesis Bio Inc do?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Companies with book/share similar to Telesis Bio Inc
- Genesys Industries has Book/Share of 0.00
- Leaf Resources has Book/Share of 0.00
- Ampio Pharmaceuticals Inc has Book/Share of 0.00
- PARKD has Book/Share of 0.00
- Bluechiip has Book/Share of 0.00
- dynaCERT has Book/Share of 0.00
- Telesis Bio Inc has Book/Share of 0.00
- Constellation Technologies has Book/Share of 0.00
- Mount Ridley Mines has Book/Share of 0.00
- Traka Resources has Book/Share of 0.00
- Peppermint Innovation has Book/Share of 0.00
- Colonnade Acquisition has Book/Share of 0.00
- DynaCERT has Book/Share of 0.00